Publications
Regulating Prices Paid by the NHS for Medicines Supplied by the UK-Based Pharmaceutical Industry
1 October 1997
The aim of this paper is to review alternative methods of regulating the price of pharmaceuticals bought by the NHS from the perspective of the experience of the economic regulation of other industries in the UK, notably the privatised utilities.
Hospital Acquired Infection
8 January 1997
‘About one in ten patients in acute hospitals at any one time has an infection acquired after admission to hospitals’ (DH/PHLS, 1995, pi). This quotation, introducing…
NHS Waiting Lists: Towards the Elusive Solution
1 August 1997
Much has been written over the last 40 years bemoaning the state of NHS waiting lists. Contributions to this literature have come from diverse fields; from…
Guidelines for the Economic Evaluation of Pharmaceuticals: Can the UK learn from Australia and Canada?
1 May 1997
Getting value for money from the use of pharmaceuticals is crucial for the NHS. This publication explores the role for guidelines in generating good quality value for money information examining the experience of Australia, Canada and the UK – the first three health care systems to introduce national guidelines for economic assessments.
The Pros and Cons of Modelling in Economic Evaluation
1 May 1997
The participants were: Professor Bernard Bloom. University of Pennsylvania, USA Professor Martin Buxton. Director of the Health Economics Research Group, University of Brunel, UK Professor Michael…
Trade and Price Differentials for Pharmaceuticals: Policy Options
1 May 1997
The purpose of this paper is to examine the welfare arguments for international price differences for pharmaceuticals and the welfare effects of policies that have the…
Deep Vein Thrombosis and Pulmonary Embolism
10 January 1996
Thrombosis had been recognised as a disease since around 2000 BC, but the word thrombosis was first used by Claudius Galenos (130 – 200 AD). Pulmonary…
Uses of Models in Economic Evaluations of Medicines and Other Health Technologies
1 October 1996
The use of models in economic studies evaluating medicines and other health technologies has become a controversial issue. This is because study results now matter –…
The Doctor’s (Ethical and Economic) Dilemma
1 August 1996
In this OHE lecture Professor Sackett sets out a compelling case for evidence-based medicine to be at the core of a comprehensive, tax-funded NHS that enjoys…